DOCSLIB.ORG
Sign Up
Log In
Upload
Search
Sign Up
Log In
Upload
Home
» Tags
» Gusperimus
Gusperimus
Fig. L COMPOSITIONS and METHODS to INHIBIT STEM CELL and PROGENITOR CELL BINDING to LYMPHOID TISSUE and for REGENERATING GERMINAL CENTERS in LYMPHATIC TISSUES
(12) Patent Application Publication (10) Pub. No.: US 2017/0209462 A1 Bilotti Et Al
Pharmaceuticals and Medical Devices Safety Information No
Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1
BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available
Prescription Medications, Drugs, Herbs & Chemicals Associated With
Controlled, Parallel Group Phase 2A Study to Assess the Efficacy of Ro5459072 in Patients with Primary Sjögren’S Syndrome
United States Patent (19) 11 Patent Number: 5,916,910 Lai (45) Date of Patent: Jun
58 69 Success of the European Orphan Medicines Regime.Fm
Stembook 2018.Pdf
Targeting the Monocyte–Macrophage Lineage in Solid Organ Transplantation
Gusperimus Hydrochloride (Rinnm) 1
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes